Vanda Pharmaceuticals reported $57K in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US USD 16K 0
Agios Pharmaceuticals AGIO:US USD 71K 0
Akebia Therapeutics AKBA:US USD 2K 0
Alnylam Pharmaceuticals ALNY:US USD 1.23M 20K
Anika Therapeutics ANIK:US USD 146K 0
AstraZeneca AZN:LN USD 387M 0
Bluebird Bio BLUE:US USD 829K 94K
Clovis Oncology CLVS:US USD 145K 1000
Enanta Pharmaceuticals ENTA:US USD 208K 1000
Esperion Therapeutics ESPR:US USD 72K 7K
Halozyme Therapeutics HALO:US USD 135K 3K
Heron Therapeutics HRTX:US USD 1.19M 163K
Insmed INSM:US USD 1.22M 18K
Intercept Pharmaceuticals ICPT:US USD 41K 11K
Lexicon Pharmaceuticals LXRX:US USD 189K 39K
Minerva Neurosciences NERV:US USD 1000 0
Moderna Inc MRNA:US USD 38.7K 500
Novartis NVS:US USD 890M 0
Ptc Therapeutics PTCT:US USD 71K 0
Sangamo Biosciences SGMO:US USD 1.62M 85K
Takeda 4502:JP JPY 1.68T 4M
Teva Pharmaceutical TEVA:IT USD 57M 19.86B
Ultragenyx Pharmaceutical RARE:US USD 70K 0
Vanda Pharmaceuticals VNDA:US USD 57K 0
Veracyte VCYT:US USD 72K 0